2-(4-氯苯基)-1H-吲哚-3-甲醛 | 1217-83-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 2-(4-氯苯基)-1H-吲哚-3-甲醛
• 英文名称: 2-(4-chlorophenyl)-1H-indole-3-carbaldehyde
• 英文别名: 2-p-chlorophenylindole-3-aldehyde
• CAS: 1217-83-0
• 化学式: C₁₅H₁₀ClNO
• mdl: MFCD00047160
• 分子量: 255.703
• InChiKey: LISKDSDZIWRRTD-UHFFFAOYSA-N

物化性质

• 熔点：
  263-265 °C
• 沸点：
  485.6±35.0 °C(Predicted)
• 密度：
  1.340±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  32.9
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2933990090
• 安全说明：
  S24/25

SDS

Name:	2-(4-Chlorophenyl)-1h-indole-3-carbaldehyde 97% Material Safety Data Sheet
Synonym:
CAS:	1217-83-0

Section 1 - Chemical Product MSDS Name:2-(4-Chlorophenyl)-1h-indole-3-carbaldehyde 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
1217-83-0	2-(4-Chlorophenyl)-1H-indole-3-carbald	97%	unlisted

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 1217-83-0: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C15H10ClNO
Molecular Weight: 256

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 1217-83-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-(4-Chlorophenyl)-1H-indole-3-carbaldehyde - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 1217-83-0: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 1217-83-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1217-83-0 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-(4-氯苯基)-1H-吲哚-3-甲醛 在 盐酸羟胺 、 三乙胺 作用下， 以 乙醇 为溶剂， 反应 1.0h， 生成 2-(4-chlorophenyl)-1H-indole-3-carbaldehyde oxime
  参考文献：
  名称：

  3-(2-aryl-1H-INDOL-3-YL)-4-AROYL-5-芳基异恶唑啉的合成

  摘要：

  4. C. Ding, R. Batorsky, R. Bhide, HJ Chao, Y. Cho, S. Chong, J. Gullo-Brown, P. Guo, SH Kim, F. Lee, K. Leftheris, A. Miller, T. Mitt、M. Patel、BA Penhallow、C. Ricca、WC Rose、R. Schmidt、WA Slusarchyk、G. Vite、N. Yan、V. Manne 和 JT Hunt,J。医学。化学，42,5241 (1999)。5. YR Rao、M. Mapuji 和 SN Mahapatra，Org。准备。过程 国际，14,199 (1982)。6. T. Nagasaka 和 YJ Koseki，J。组织。化学，63,6797 (1998)。7. J.-M. Huang、H. Chen 和 R.-Y。陈，合成。公社，32

  DOI：

  10.1080/00304940809458114
• 作为产物：
  描述：

  苯肼 在 甲烷磺酸 、 溶剂黄146 、 三氯氧磷 作用下， 反应 1.0h， 生成 2-(4-氯苯基)-1H-吲哚-3-甲醛
  参考文献：
  名称：

  发现具有针对DNA促旋酶的抗菌活性的新型多取代苯并吲哚吡唑席夫碱衍生物。

  摘要：

  具有强大的DNA回旋酶抑制活性的新型多取代苯并吲哚吡唑Schiff碱衍生物的设计与合成是本研究的主要目的。检查所有新合成的化合物对金黄色葡萄球菌，单核细胞增生性李斯特菌，大肠埃希菌和沙门氏菌的抗菌活性。此外，我们选择了20种化合物用于6种耐药菌菌株的体外抗菌活性测定。结果表明，化合物8I-w对4种耐药大肠杆菌菌株表现出优异的抗菌活性，IC50值分别为7.0、17.0、13.5和1.0μM。体外酶抑制试验表明，化合物8I-w对DNA促旋酶显示出有效的抑制作用，IC50值为0.10μM。分子对接模型表明化合物8I-w可通过与各种氨基酸残基相互作用而与DNA促旋酶良好结合。这项研究表明，化合物8I-w可以作为已报道的一系列化合物中最有效的DNA促旋酶抑制剂，并为商业化的抑制DNA促旋酶的杀菌剂提供有价值的信息。

  DOI：

  10.1016/j.bioorg.2020.103807

文献信息

• Indole derivatives for use as chemical uncoupler
  申请人：Christiansen Brown Lise

  公开号：US20070010559A1

  公开（公告）日：2007-01-11

  Novel 3-vinylsulfonyl indole derivatives are chemical uncouplers useful e.g. for treatment of obesity.

  3-乙烯磺酰吲哚衍生物是一种化学解偶联剂，例如可用于治疗肥胖。
• Anti-cancer, anti-oxidant and molecular docking studies of thiosemicarbazone indole-based derivatives
  作者：Zohreh Bakherad、Maliheh Safavi、Afshin Fassihi、Hojjat Sadeghi-Aliabadi、Mohammad Bakherad、Hossein Rastegar、Jahan B. Ghasemi、Saghi Sepehri、Lotfollah Saghaie、Mohammad Mahdavi

  DOI：10.1007/s11164-019-03765-9

  日期：2019.5

  Based on the structural elements of bioactive 3-substituted indoles, a new series of indole–thiosemicarbazone hybrid derivatives were designed, synthesized, and well-characterized using different spectral techniques. The intended scaffolds were screened for their in vitro anti-proliferative activities against breast cancer (MCF-7), lung cancer (A-549), and liver cancer (Hep-G2) cell lines, as well as their anti-oxidant properties. Cytotoxicity studies revealed that compound 6n was the most potent, at least threefold more potent than the commercially available reference drug etoposide, against A-549. In addition, morphological analysis by the acridine orange/ethidium bromide double staining test and flow cytometry analysis confirmed induction of apoptosis in the A-549 cells by compound 6n. In order to validate the experimental results, molecular studies were performed to achieve the possible binding interactions of the most potent compound (6n) and colchicine with tubulin as well as ANP with ATPase domain of topoisomerase IIα active sites. Moreover, the radical scavenging potential of the final derivatives was found to be excellent with the range of 0.015–0.630 µM, comparable to the standard ascorbic acid (0.655 µM).

  基于生物活性3-取代吲哚的结构元素，设计、合成了新一系列吲哚-缩氨硫脲杂化衍生物，并利用不同光谱技术对其进行了很好的表征。对这些预期的支架结构进行了体外抗增殖活性筛选，针对乳腺癌（MCF-7）、肺癌（A-549）和肝癌（Hep-G2）细胞系，以及它们的抗氧化性能。细胞毒性研究表明，化合物6n对A-549的活性最强，至少是市售参考药物依托泊苷的三倍。此外，通过吖啶橙/溴化乙锭双重染色试验和流式细胞术分析，确认化合物6n诱导A-549细胞凋亡。为了验证实验结果，进行了分子研究，以实现最强化合物（6n）和秋水仙碱与微管蛋白的可能结合相互作用，以及ANP与拓扑异构酶IIα的ATP酶域活性位点的相互作用。此外，最终衍生物的自由基清除潜力非常出色，范围为0.015-0.630 µM，与标准抗坏血酸（0.655 µM）相当。
• Propenone derivatives
  申请人：Kyowa Hakko Kogyo Co., Ltd.

  公开号：US05952355A1

  公开（公告）日：1999-09-14

  The present invention relates to propenone derivatives represented by the following formula (I): ##STR1## wherein R.sup.1 represents hydrogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, or YR.sup.5 (wherein Y represents S or O; and R.sup.5 represents substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or a substituted or unsubstituted cyclic ether residue); R.sup.2 and R.sup.3 independently represent hydrogen, lower alkyl, or substituted or unsubstituted aralkyl, or alternatively R.sup.2 and R.sup.3 are combined to form substituted or unsubstituted methylene or ethylene; R.sup.4 represents hydrogen, hydroxy, lower alkyl, substituted or unsubstituted aralkyl, lower alkoxy, substituted or unsubstituted aralkyloxy, or halogen; and X represents substituted or unsubstituted indolyl; or pharmaceutically acceptable salts thereof.

  本发明涉及以下式(I)所代表的丙酮衍生物：##STR1##其中R.sup.1代表氢、取代或未取代的较低烷基、取代或未取代的芳基，或YR.sup.5（其中Y代表S或O；R.sup.5代表取代或未取代的较低烷基、取代或未取代的芳基、取代或未取代的杂芳基，或取代或未取代的环氧基残基）；R.sup.2和R.sup.3独立地代表氢、较低烷基，或取代或未取代的芳基烷基，或者R.sup.2和R.sup.3结合形成取代或未取代的亚甲基或乙烯基；R.sup.4代表氢、羟基、较低烷基、取代或未取代的芳基烷基、较低烷氧基、取代或未取代的芳基烷氧基，或卤素；X代表取代或未取代的吲哚基；或其药学上可接受的盐。
• [EN] INDOLE DERIVATIVES FOR USE AS CHEMICAL UNCOUPLER<br/>[FR] NOUVEAUX DERIVES D'INDOLE A UTILISER COMME AGENTS DECOUPLANTS CHIMIQUES
  申请人：NOVO NORDISK AS

  公开号：WO2005051908A1

  公开（公告）日：2005-06-09

  Novel 3-vinylsulfonyl indole derivatives of formula (I) are chemical uncouplers useful e.g. for treatment of obesity.

  新型的化合物3-乙烯基磺酰基吲哚衍生物，化学解耦剂，可用于治疗肥胖等。
• Thiazolidinone/thiazole based hybrids – New class of antitrypanosomal agents
  作者：Anna Kryshchyshyn、Danylo Kaminskyy、Oleksandr Karpenko、Andrzej Gzella、Philippe Grellier、Roman Lesyk

  DOI：10.1016/j.ejmech.2019.04.052

  日期：2019.7

  have been investigated as potent drugs for trypanosomiasis treatment, but no new drug has been marketed in the past 3 decades. 4-Thiazolidinone/thiazole as privileged structures and thiosemicarbazides cyclic analogs are well known scaffolds in novel antitrypanosomal agent design. We present here the design and synthesis of new hybrid molecules bearing thiazolidinone/thiazole cores linked by the hydrazone

  已经研究了各种化合物作为治疗锥虫病的有效药物，但是在过去的30年中，没有新的药物上市。4-噻唑烷酮/噻唑作为优先结构和硫代氨基脲环类似物是新型抗锥虫药物设计中众所周知的支架。我们在这里介绍新的杂合分子的设计和合成，这些杂合分子带有由zo基与各种分子片段连接的噻唑烷酮/噻唑核。结构优化导致具有苯基吲哚或苯基咪唑并[2,1- b ] [1,3,4]噻二唑部分的化合物对布鲁氏锥虫和冈比亚锥虫具有优异的抗锥虫活性。生物学研究允许鉴定出亚微摩尔水平的IC 50，良好的选择性指数，对人原代成纤维细胞的相对较低的细胞毒性以及较低的急性毒性的化合物。